Resparray
Payments companies reported to CMS as associated with Resparray. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Resparray, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Resparray
These are the largest totals companies reported as associated with Resparray. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Basem Abdelmalak | Cleveland, OH | Anesthesiology | $208.31 |
| John Rotruck | Pearl Harbor, HI | Anesthesiology | $208.30 |
| Kiran Sembhi | Roseville, CA | Anesthesiology | $208.30 |
| Marcos Vidal Melo | Galveston, TX | Anesthesiology | $208.30 |
| Amanda Baker | Raleigh, NC | Anesthesiology | $208.30 |
| Vivek Arora | Seattle, WA | Anesthesiology | $208.30 |
| Helga Komen | Saint Louis, MO | Anesthesiology | $208.30 |
| Luke Shope | Boca Raton, FL | $208.30 | |
| Zheng Xie | Chicago, IL | Anesthesiology | $208.30 |
| Elizabeth Day | Philadelphia, PA | Adolescent Medicine (Pediatrics) | $208.30 |
Prescribed Resparray?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.